WGS detected a tumour mutational burden (TMB) of 2.9 mutations per Mega base; LOH of 0.48; homozygous deletion of BRCA2; and a dominant COSMIC mutational signature 3 (Figs. 1 and 2B,C), indicating that this uLMS was HRD. The gene discussed is BRCA2; the disease is neoplasm.